Immunovant IMVT
NASDAQ IMVT
$33.46 -0.03 (-0.09%)
At close: Sep 29, 2026 · 4:00 PM EDT

Immunovant (IMVT) Assets (2018 - 2026)

Updated

Immunovant (IMVT) posted Assets of $852.49 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 28.9% from $661.44 million a year earlier but down 10.9% from the prior quarter.

Analysis

Immunovant (IMVT) Assets (2018 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Immunovant's Assets came in at $957.01 million, up 23.3% from FY2025.

  • Annual Assets has increased for three consecutive fiscal years, with a five-year compound annual growth rate of 18.3% (FY2021 to FY2026).
  • In prior fiscal years, Immunovant's Assets was $776.22 million in FY2025 (+16.5%), $666.37 million in FY2024 (+64.2%), $405.84 million in FY2023 (-21.3%) and $515.56 million in FY2022 (+25.0%).
  • Quarterly Assets has run from a low of $292.07 million in fiscal Q2 2024 to a high of $1.05 billion in fiscal Q3 2026 over five years.
  • On a year-over-year basis, Assets has increased in each of the last six quarters, with growth averaging 35.0% over the last eight quarters.
  • The strongest year-over-year quarter for Assets in the past five years was fiscal Q3 2026, with growth of 150.0%; the weakest was fiscal Q3 2025, with a decline of 40.8%.
  • According to Business Quant data, Assets for the three prior fiscal quarters was $957.01 million (Q4 2026), $1.05 billion (Q3 2026) and $582.96 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 201.06 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 135.12 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 115.83 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 49.36 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 27.42 Bn
10 Immunovant 6.91 Bn 6.91 Bn - 852.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 852.49 Mn
Mar 31, 2026 957.01 Mn
Dec 31, 2025 1.05 Bn
Sep 30, 2025 582.96 Mn
Jun 30, 2025 661.44 Mn
Mar 31, 2025 776.22 Mn
Dec 31, 2024 420.93 Mn
Sep 30, 2024 515.71 Mn
Jun 30, 2024 589.68 Mn
Mar 31, 2024 666.37 Mn
Dec 31, 2023 711.45 Mn
Sep 30, 2023 292.07 Mn
Jun 30, 2023 351.22 Mn
Mar 31, 2023 405.84 Mn
Dec 31, 2022 456.24 Mn
Sep 30, 2022 428.15 Mn
Jun 30, 2022 458.66 Mn
Mar 31, 2022 515.56 Mn
Dec 31, 2021 543.18 Mn
Sep 30, 2021 566.73 Mn
API Access

Immunovant Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=IMVT&period=max&api_key=YOUR_API_KEY